Is Teva Neuroscience, Inc. FDA approved?

Teva Neuroscience, Inc. holds no registered establishment of its own; 17 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Teva Neuroscience, Inc. make?

17 products are listed under Teva Neuroscience, Inc. in the openFDA NDC Directory, most often as tablet, film coated, extended release; tablet, coated; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Teva Neuroscience, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 17
Live patents: 230
Countries: 0

Catalogue

Drug listings by form and route

17 active NDC listings: 17 human prescription drug. By marketing category: NDA 17.

Dosage form	NDCs
tablet, film coated, extended release	8
tablet, coated	3
injection, solution	2
kit	2
tablet	2

Route	NDCs
oral	13
subcutaneous	2

Labeller name on the listing	NDCs
teva neuroscience, inc.	17

Exclusivity

Patents and exclusivities

230

Patent	Product	Covers	Expiry
7572834	AZILECTrasagiline mesylate	product	Dec 2026
7815942	AZILECTrasagiline mesylate	substance, product	Aug 2027
8221778	UZEDYrisperidone	product	Nov 2027
8741327	UZEDYrisperidone	product	Nov 2027
8524733	AUSTEDO XRdeutetrabenazine	substance, product	Apr 2031
8524733*PED	AUSTEDO XRdeutetrabenazine	use	Oct 2031
9023897	UZEDYrisperidone	product	Apr 2033
9550780	AUSTEDO XRdeutetrabenazine	substance, product	Sept 2033
9550780*PED	AUSTEDO XRdeutetrabenazine	use	Mar 2034
10959996	AUSTEDO XRdeutetrabenazine	use	Mar 2036
11357772	AUSTEDO XRdeutetrabenazine	use	Mar 2036
11446291	AUSTEDO XRdeutetrabenazine	use	Mar 2036
11564917	AUSTEDO XRdeutetrabenazine	use	Mar 2036
11648244	AUSTEDO XRdeutetrabenazine	use	Mar 2036
12016858	AUSTEDO XRdeutetrabenazine	use	Mar 2036
10959996*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
11357772*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
11446291*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
11564917*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
11648244*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
12016858*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2036
11179386	AUSTEDO XRdeutetrabenazine	product	Mar 2038
11813232	AUSTEDO XRdeutetrabenazine	product	Mar 2038
11179386*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2038
11813232*PED	AUSTEDO XRdeutetrabenazine	use	Sept 2038
12128132	UZEDYrisperidone	product	Sept 2040
12383493	UZEDYrisperidone	product	Sept 2040
11311488	AUSTEDO XRdeutetrabenazine	product	Jun 2041
12589075	AUSTEDO XRdeutetrabenazine	use	Jun 2041
12599598	AUSTEDO XRdeutetrabenazine	use	Jun 2041
12329851	UZEDYrisperidone	use	Mar 2042

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
AUSTEDO	deutetrabenazine	kit	68546-176NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-470NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-471NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-472NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-473NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-474NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-475NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-476NDA
AUSTEDO XR	deutetrabenazine	kit	68546-477NDA
AUSTEDO XR	deutetrabenazine	tablet, film coated, extended release, oral	68546-479NDA
Austedo	Deutetrabenazine	tablet, coated, oral	68546-170NDA
Austedo	Deutetrabenazine	tablet, coated, oral	68546-171NDA
Austedo	Deutetrabenazine	tablet, coated, oral	68546-172NDA
Azilect	Rasagiline mesylate	tablet, oral	68546-142NDA
Azilect	Rasagiline mesylate	tablet, oral	68546-229NDA
Copaxone	Glatiramer Acetate	injection, solution, subcutaneous	68546-317NDA
Copaxone	Glatiramer Acetate	injection, solution, subcutaneous	68546-325NDA

Enquiry

Common questions

Is Teva Neuroscience, Inc. FDA approved?: Teva Neuroscience, Inc. holds no registered establishment of its own; 17 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Teva Neuroscience, Inc. make?: 17 products are listed under Teva Neuroscience, Inc. in the openFDA NDC Directory, most often as tablet, film coated, extended release; tablet, coated; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.